We often talk about the importance of planning for pregnancy. In these discussions, we emphasize the importance of supplementation with folic acid as a means of decreasing risk for birth defects and improving neurodevelopmental [...]
Publish date: September 10, 2019 By Lee S. Cohen, MD The last decade has brought increasing awareness of the need to effectively screen for postpartum depression, with a majority of states across the country now having [...]
In a recent study, Chinese researchers looked at the prevalence of depression and anxiety among women who had experienced recurrent pregnancy loss (RPL, defined as 3 or more losses). The study included 1138 non-pregnant [...]
This week there are several articles looking at the impact of various factors on the quality of mother-infant bonding. The largest study from Tichelman and colleagues indicates that, out of 123 factors studied, three of [...]
We are now open for those who would like to register for our online course in Women’s Mental Health. This course will focus on the diagnosis and treatment of psychiatric disorders in women across the [...]
A meta-analysis of 24 studies, including 99,614 women, demonstrated higher levels of depression among women with endometriosis compared to unaffected controls. When researchers restricted the analysis to healthy controls, the association between endometriosis and depression [...]
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new postpartum depression medication Zulresso (brexanolone) with Ob.Gyn News on August 20th, [...]
It has been a few months since Zulresso (brexanolone), the new FDA-approved treatment for postpartum depression, has been available. At our clinic, we have had multiple queries regarding how to obtain treatment with Zulresso. One [...]
On this week’s list, we have multiple articles on the impact of perinatal mood and anxiety disorders on the pregnancy and on the family. While we clearly see an increased interest in identifying women with [...]
Not infrequently we see women who ask about the possibility of oophorectomy (surgical removal of the ovaries) as a means of managing what appears to be a menstrually related mood disorder. While this is an [...]
